A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Bristol-Myers Squibb
Eucure (Beijing) Biopharma Co., Ltd
Fred Hutchinson Cancer Center
University College, London
Charite University, Berlin, Germany